Filing Details

Accession Number:
0001213900-14-009104
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-24 10:05:25
Reporting Period:
2014-12-22
Filing Date:
2014-12-24
Accepted Time:
2014-12-24 10:05:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
812796 Soligenix Inc. SNGX Pharmaceutical Preparations (2834) 411505029
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1468000 Michael Joseph Warusz 29 Emmons Drive, Suite C-10
Princeton NJ 08540
Vp Of Finance/Acting Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-12-22 8,265 $1.21 12,955 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrant Acquisiton 2014-12-24 4,959 $0.00 4,959 $1.48
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,959 2014-12-22 2019-12-22 No 4 P Direct